EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry

Lijiang Zhang, Danyang Liu, Xueying Xiang, Suhang Wu, Congcong Wen, Xianqin Wang

Biomedical Chromatography · 2026-12 · 40 (12)

DOI: 10.1002/bmc.70652 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Haplopine, a furoquinoline alkaloid with documented anti‐inflammatory, antioxidant, and anti‐atopic dermatitis properties, has not yet been characterized with respect to its in vivo disposition. Here, we developed a fast UPLC‐MS/MS assay for quantifying haplopine in mouse blood. Aliquots of 20 μL of blood were subjected to acetonitrile‐based protein precipitation and resolved on a BEH C18 column within a 4‐min run. Quantification was performed in the positive‐ion electrospray multiple reaction monitoring mode, monitoring the transitions m/z 246.2 → 231.3 for haplopine and m/z 326.2 → 291.4 for the internal standard. The method was linear over 1–1000 ng/mL ( r 2 = 0.9998), with intra‐ and inter‐day precision below 13% and 11%, respectively; accuracy ranged from 90.2% to 110.8%, recovery exceeded 87.2%, and matrix effects were 92.8%–99.1%. The validated assay was then applied to study the pharmacokinetics of haplopine in mice following intravenous (2.0 mg/kg) and oral (8 and 16 mg/kg) administration. Absolute oral bioavailability reached 39.1% and 55.0% at 8 and 16 mg/kg, respectively, indicating moderate, dose‐dependent systemic bioavailability. Collectively, these data constitute the first pharmacokinetic description of haplopine and provide a foundation for its continued development.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →